v3.25.2
Restructuring (Tables)
6 Months Ended
Jun. 29, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve
The following table summarizes the restructuring expenses for 2025 and 2024:
(Pre-tax Dollars in Millions)Q2 2025Q2 2024Q2 YTD 2025Q2 YTD 2024
MedTech Segment Surgery franchise(1)
$2929
MedTech Segment Orthopaedics franchise(2)
505210579
Innovative Medicine Segment(3)
(63)81
Total Programs$79(11)134160
(1)Included in Restructuring on the Consolidated Statement of Earnings in the fiscal second quarter and fiscal six months of 2025.
(2)Included $35 million in Restructuring and $15 million in Cost of products sold on the Consolidated Statement of Earnings in the fiscal second quarter of 2025. Included $52 million in Restructuring, $23 million in Cost of products sold and $30 million in Other (Income)/Expense on the Consolidated Statement of Earnings in the fiscal six months of 2025. Included $50 million in Restructuring and $2 million in Cost of products sold on the Consolidated Statement of Earnings in the fiscal second quarter of 2024. Included $70 million in Restructuring and $9 million in Cost of products sold on the Consolidated Statement of Earnings in the fiscal six months of 2024.
(3)Included in Restructuring on the Consolidated Statement of Earnings. This program was completed in the fiscal fourth quarter of 2024.